Related references
Note: Only part of the references are listed.Mechanisms of HBV-induced hepatocellular carcinoma
Massimo Levrero et al.
JOURNAL OF HEPATOLOGY (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents
Irina A. Vasilevskaya et al.
CLINICAL CANCER RESEARCH (2015)
Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells
Qiongshu Li et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
Subconjunctival Injection of XG-102, a JNK Inhibitor Peptide, in Patients with Intraocular Inflammation: A Safety and Tolerability Study
Talal Beydoun et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2015)
Subconjunctival Injection of XG-102, a c-Jun N-Terminal Kinase Inhibitor Peptide, in the Treatment of Endotoxin-Induced Uveitis in Rats
Ikram El Zaoui et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2015)
Toll-like receptor 4 signaling promotes invasion of hepatocellular carcinoma cells through MKK4/JNK pathway
Yu-Qing Dong et al.
MOLECULAR IMMUNOLOGY (2015)
Mucin1 promotes the migration and invasion of hepatocellular carcinoma cells via JNK-mediated phosphorylation of Smad2 at the C-terminal and linker regions
Juan Wang et al.
ONCOTARGET (2015)
Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway
Chih-Hsing Chou et al.
ONCOTARGET (2015)
Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21WAF1 pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells
Qiongshu Li et al.
ONCOTARGET (2015)
Inhibitors of c-Jun N-Terminal Kinases: An Update
Pierre Koch et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin
Jantine PosthumadeBoer et al.
Oncotarget (2015)
Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro
Brian I. Carr et al.
BMC CANCER (2014)
CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma
Rajeswara Rao Pannem et al.
CARCINOGENESIS (2014)
Reversible phospho-Smad3 signalling between tumour suppression and fibrocarcinogenesis in chronic hepatitis B infection
Y. -R. Deng et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
SP600125 overcomes antimitotic drug-resistance in cancer cells by increasing apoptosis with independence of P-gp inhibition
Ju-Hwa Kim et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Sorafenib enhances proteasome inhibitor-induced cell death via inactivation of Akt and stress-activated protein kinases
Yuichi Honma et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Efficacy and Safety of AM-111 in the Treatment of Acute Sensorineural Hearing Loss
Markus Suckfuell et al.
OTOLOGY & NEUROTOLOGY (2014)
MUC1: a multifaceted oncoprotein with a key role in cancer progression
Sritama Nath et al.
TRENDS IN MOLECULAR MEDICINE (2014)
LPS promotes epithelial-mesenchymal transition and activation of TLR4/JNK signaling
Hangyu Li et al.
TUMOR BIOLOGY (2014)
c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo
A. Sclip et al.
CELL DEATH & DISEASE (2014)
Longikaurin A, a natural ent-kaurane, induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cells
Y-J Liao et al.
CELL DEATH & DISEASE (2014)
Altered Mucins (MUC) Trafficking in Benign and Malignant Conditions
Suhasini Joshi et al.
ONCOTARGET (2014)
Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells
Maroof Alam et al.
ONCOTARGET (2014)
Determination of tissue levels of a neuroprotectant drug: The cell permeable JNK inhibitor peptide
Enrico Davoli et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2014)
The dual mTORC1 and mTORC2 inhibitor AZD8055 inhibits head and neck squamous cell carcinoma cell growth in vivo and in vitro
Qiang Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
iNOS promotes HBx-induced hepatocellular carcinoma via upregulation of JNK activation
Young-Ho Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
MUC1 activates JNK1 and inhibits apoptosis under genotoxic stress
Qiongqiong Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Smad phospho-isoforms direct context-dependent TGF-β signaling
Koichi Matsuzaki
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Lipopolysaccharide-Induced Toll-Like Receptor 4 Signaling in Cancer Cells Promotes Cell Survival and Proliferation in Hepatocellular Carcinoma
Lili Wang et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
Phosphorylated Smad2 and Smad3 signaling: Shifting between tumor suppression and fibro-carcinogenesis in chronic hepatitis C
Takashi Yamaguchi et al.
HEPATOLOGY RESEARCH (2013)
Epidemiology of Hepatocellular Carcinoma Consider the Population
Sahil Mittal et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Molecular mechanisms involved in cochlear implantation trauma and the protection of hearing and auditory sensory cells by inhibition of c-jun-N-terminal kinase signaling
Adrien A. Eshraghi et al.
LARYNGOSCOPE (2013)
Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuroinflammation and apoptosis after neonatal ischemic brain damage
Cora H. Nijboer et al.
NEUROBIOLOGY OF DISEASE (2013)
MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches
D. W. Kufe
ONCOGENE (2013)
Wentilactone B induces G2/M phase arrest and apoptosis via the Ras/Raf/MAPK signaling pathway in human hepatoma SMMC-7721 cells
Z. Zhang et al.
CELL DEATH & DISEASE (2013)
MUC1 and metastatic cancer Expression, function and therapeutic targeting
Teresa M. Horm et al.
CELL ADHESION & MIGRATION (2013)
Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis
Nicole Reich et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor
Veronique Plantevin Krenitsky et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Inhibition of adrenergic human prostate smooth muscle contraction by the inhibitors of c-Jun N-terminal kinase, SP600125 and BI-78D3
F. Strittmatter et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Discovery of Potent and Selective Covalent Inhibitors of JNK
Tinghu Zhang et al.
CHEMISTRY & BIOLOGY (2012)
Selective killing of p53-deficient cancer cells by SP600125
Mohamed Jemaa et al.
EMBO MOLECULAR MEDICINE (2012)
A Liver Full of JNK: Signaling in Regulation of Cell Function and Disease Pathogenesis, and Clinical Approaches
Ekihiro Seki et al.
GASTROENTEROLOGY (2012)
Inhibition of MKK7-JNK by the TOR Signaling Pathway Regulator-Like Protein Contributes to Resistance of HCC Cells to TRAIL-Induced Apoptosis
In Sung Song et al.
GASTROENTEROLOGY (2012)
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
Catherine de Martel et al.
LANCET ONCOLOGY (2012)
Specific inhibition of the JNK pathway promotes locomotor recovery and neuroprotection after mouse spinal cord injury
Mariaelena Repici et al.
NEUROBIOLOGY OF DISEASE (2012)
The JNK Inhibitor XG-102 Protects against TNBS-Induced Colitis
Kirstin Reinecke et al.
PLOS ONE (2012)
AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer Cells
Angelo Cerbone et al.
PPAR RESEARCH (2012)
Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways
Radhamani Kannaiyan et al.
APOPTOSIS (2011)
JNK-1 Deficiency Limits Macrophage-Mediated Antigen-Induced Arthritis
Monica Guma et al.
ARTHRITIS AND RHEUMATISM (2011)
Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice
Chun-Li Xiao et al.
BMC CANCER (2011)
The role of JNK in the development of hepatocellular carcinoma
Madhumita Das et al.
GENES & DEVELOPMENT (2011)
Suppression by Heat Shock Protein 20 of Hepatocellular Carcinoma Cell Proliferation via Inhibition of the Mitogen-Activated Protein Kinases and AKT Pathways
Rie Matsushima-Nishiwaki et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells
J. Merlin et al.
ONCOGENE (2011)
Protection Against Ischemic Cochlear Damage by Intratympanic Administration of AM-111
Yoshinori Omotehara et al.
OTOLOGY & NEUROTOLOGY (2011)
c-Jun N-terminal kinase (JNK) signaling: Recent advances and challenges
Marie A. Bogoyevitch et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Induction of DNA Damage-Inducible Gene GADD45β Contributes to Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Cells
Da-Liang Ou et al.
CANCER RESEARCH (2010)
c-Jun N-Terminal Kinase Pathway Inhibition in Intracerebral Hemorrhage
Delphine Michel-Monigadon et al.
CEREBROVASCULAR DISEASES (2010)
The JNK inhibitor SP600125 enhances dihydroartemisinin-induced apoptosis by accelerating Bax translocation into mitochondria in human lung adenocarcinoma cells
Ying-Ying Lu et al.
FEBS LETTERS (2010)
Adiponectin Modulates C-Jun N-Terminal Kinase and Mammalian Target of Rapamycin and Inhibits Hepatocellular Carcinoma
Neeraj K. Saxena et al.
GASTROENTEROLOGY (2010)
Chemopreventive and anti-cancer properties of the aqueous extract of flowers of Butea monosperma
Tenzin Choedon et al.
JOURNAL OF ETHNOPHARMACOLOGY (2010)
Diverse somatic mutation patterns and pathway alterations in human cancers
Zhengyan Kan et al.
NATURE (2010)
The c-Jun N-terminal kinase (JNK) inhibitor XG-102 enhances the neuroprotection of hyperbaric oxygen after cerebral ischaemia in adult rats
J-R. Liu et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2010)
Oncogenic mutations regulate tumor microenvironment through induction of growth factors and angiogenic mediators
S. E. Wang et al.
ONCOGENE (2010)
SP600125 suppresses Cdk1 and induces endoreplication directly from G2 phase, independent of JNK inhibition
J. A. Kim et al.
ONCOGENE (2010)
KITENIN Is Associated With Activation of AP-1 Target Genes via MAPK Cascades Signaling in Human Hepatocellular Carcinoma Progression
Sung-Bum Cho et al.
ONCOLOGY RESEARCH (2010)
8-bromo-7-methoxychrysin-induced apoptosis of hepatocellular carcinoma cells involves ROS and JNK
Xiao-Hong Yang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
A Peptide Inhibitor of c-Jun N-Terminal Kinase for the Treatment of Endotoxin-Induced Uveitis
Elodie Touchard et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Selective inhibition of JNK with a peptide inhibitor attenuates pain hypersensitivity and tumor growth in a mouse skin cancer pain model
Yong-Jing Gao et al.
EXPERIMENTAL NEUROLOGY (2009)
JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand
S. R. Mucha et al.
GUT (2009)
Differential Effects of JNK1 and JNK2 Inhibition on Murine Steatohepatitis and Insulin Resistance
Rajat Singh et al.
HEPATOLOGY (2009)
Hepatitis B Virus X Protein Shifts Human Hepatic Transforming Growth Factor (TGF)-β Signaling from Tumor Suppression to Oncogenesis in Early Chronic Hepatitis B
Miki Murata et al.
HEPATOLOGY (2009)
Inhibition of c-Jun NH2-Terminal Kinase Switches Smad3 Signaling from Oncogenesis to Tumor-Suppression in Rat Hepatocellular Carcinoma
Hiromitsu Nagata et al.
HEPATOLOGY (2009)
Melittin, a Major Component of Bee Venom, Sensitizes Human Hepatocellular Carcinoma Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis by Activating CaMKII-TAK1-JNK/p38 and Inhibiting IκBα Kinase-NFκB (Publication with Expression of Concern. See vol. 295, pg. 8880, 2020) (Withdrawn Publication. See vol. 296, 2021)
Chen Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
JNK1-dependent PUMA Expression Contributes to Hepatocyte Lipoapoptosis
Sophie C. Cazanave et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer
Qingshan Chang et al.
JOURNAL OF HEPATOLOGY (2009)
Dysregulation of apoptosis in hepatocellular carcinoma cells
Isabel Fabregat
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Mucins in cancer: function, prognosis and therapy
Donald W. Kufe
NATURE REVIEWS CANCER (2009)
Signal integration by JNK and p38 MAPK pathways in cancer development
Erwin F. Wagner et al.
NATURE REVIEWS CANCER (2009)
The JNK inhibitor XG-102 protects from ischemic damage with delayed intravenous administration also in the presence of recombinant tissue plasminogen activator
Karine Wiegler et al.
CEREBROVASCULAR DISEASES (2008)
Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease
Puneet Puri et al.
GASTROENTEROLOGY (2008)
Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation
Lijian Hui et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Downregulation of CD147 expression alters cytoskeleton architecture and inhibits gelatinase production and SAPK pathway in human hepatocellular carcinoma cells
Ai-Rong Qian et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)
The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX
Ileana Aderca et al.
JOURNAL OF HEPATOLOGY (2008)
JNK signaling in apoptosis
D. N. Dhanasekaran et al.
ONCOGENE (2008)
Identification of a new JNK inhibitor targeting the JNK-JIP interaction site
John L. Stebbins et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease
Harmeet Malhi et al.
SEMINARS IN LIVER DISEASE (2008)
Induction of endoreduplication by a JNK inhibitor SP600125 in human lung carcinoma A 549 cells
Yumi Miyamoto-Yamasaki et al.
CELL BIOLOGY INTERNATIONAL (2007)
MUC1 oncoprotein activates the IκB kinase β complex and constitutive NF-κB signalling
Rehan Ahmad et al.
NATURE CELL BIOLOGY (2007)
Cell signaling in oxidative stress-induced liver injury
Mark J. Czaja
SEMINARS IN LIVER DISEASE (2007)
Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity
Harmeet Malhi et al.
GUT (2007)
Insulin protects liver cells from saturated fatty acid-induced apoptosis via inhibition of c-Jun NH2 terminal kinase activity
M. J. Pagliassotti et al.
ENDOCRINOLOGY (2007)
Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor β signaling, promoting cirrhosis and hepatocellular carcinoma
Koichi Matsuzaki et al.
HEPATOLOGY (2007)
Acetaldehyde induces matrix metalloproteinase-9 gene expression via nuclear factor-κB and activator protein 1 signaling pathways in human hepatocellular carcinoma cells:: Association with the invasive potential
Chien-Yun Hsiang et al.
TOXICOLOGY LETTERS (2007)
Reversible smad-dependent signaling between tumor suppression and oncogenesis
Go Sekimoto et al.
CANCER RESEARCH (2007)
Role of mitogen-activated protein kinase kinase 4 in cancer
A. J. Whitmarsh et al.
ONCOGENE (2007)
Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases
D. M. Owens et al.
ONCOGENE (2007)
P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation
Yick-Pang Ching et al.
CANCER RESEARCH (2007)
Patterns of somatic mutation in human cancer genomes
Christopher Greenman et al.
NATURE (2007)
Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene
Xiaolong Wei et al.
CANCER RESEARCH (2007)
Survival and apoptosis: a dysregulated balance in liver cancer
Isabel Fabregat et al.
LIVER INTERNATIONAL (2007)
Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases
Marie A. Bogoyevitch et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2006)
Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells
Yuren Wei et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells
Bong-Jo Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation
Toshiharu Sakurai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The NF-κB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease
S Papa et al.
CELL DEATH AND DIFFERENTIATION (2006)
Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis
H Malhi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: Respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance
ZY Zhuang et al.
JOURNAL OF NEUROSCIENCE (2006)
JNK1 but not JNK2 promotes the development of steatohepatitis in mice
JM Schattenberg et al.
HEPATOLOGY (2006)
Hepatocellular carcinoma pathogenesis: from genes to environment
Paraskevi A. Farazi et al.
NATURE REVIEWS CANCER (2006)
MUC1 oncoprotein blocks glycogen synthase kinase 3β-mediated phosphorylation and degradation of β-catenin
L Huang et al.
CANCER RESEARCH (2005)
Insulin resistance: A metabolic pathway to chronic liver disease
E Bugianesi et al.
HEPATOLOGY (2005)
Protein kinase p-JNK is correlated with the activation of AP-1 and its associated Jun family proteins in hepatocellular carcinoma
LL Guo et al.
LIFE SCIENCES (2005)
Inhibition of c-jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M CO cycle arrest
C Kuntzen et al.
CANCER RESEARCH (2005)
Apoptosis: a mechanism of acute and chronic liver injury
ME Guicciardi et al.
GUT (2005)
JNK mediates hepatic ischemia reperfusion injury
T Uehara et al.
JOURNAL OF HEPATOLOGY (2005)
A small molecule-kinase interaction map for clinical kinase inhibitors
MA Fabian et al.
NATURE BIOTECHNOLOGY (2005)
Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells
AM Mingo-Sion et al.
ONCOGENE (2004)
Hepatocyte apoptosis, expression of death receptors, and activation of NF-κB in the liver of nonalcoholic and alcoholic steatohepatitis patients
PS Ribeiro et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
The critical features and the mechanism of inhibition of a kinase interaction motif-based peptide inhibitor of JNK
RK Barr et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
c-Jun N-terminal kinase mediates hepatic injury after rat liver transplantation
T Uehara et al.
TRANSPLANTATION (2004)
Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats
C Ferrandi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Effect of an inhibitor of Jun N-terminal protein kinase, SP600125, in single allergen challenge in sensitized rats
PR Eynott et al.
IMMUNOLOGY (2004)
AS601245 (1,3-benzothiazol-2-yl(2-{[2-(3-pyridinyl)ethyl]amino}-4 pyrimidinyl) acetonitrile):: A c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties
S Carboni et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
JNK activation is critical for Aplidin™-induced apoptosis
A Cuadrado et al.
ONCOGENE (2004)
Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis
AE Feldstein et al.
GASTROENTEROLOGY (2003)
Targeting JNK for therapeutic benefit: From JuNK to gold?
AM Manning et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis
K Lei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Alteration of intrahepatic cytokine expression and AP-1 activation in transgenic mice expressing hepatitis C virus core protein
T Tsutsumi et al.
VIROLOGY (2002)
A central role for JNK in obesity and insulin resistance
J Hirosumi et al.
NATURE (2002)
JNK phosphorylation and activation of BAD couples the stress-activated signaling pathway to the cell death machinery
N Donovan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis
IT De Almeida et al.
CLINICAL NUTRITION (2002)
The JNK signal transduction pathway
CR Weston et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2002)
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
BL Bennett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis
V Nehra et al.
DIGESTIVE DISEASES AND SCIENCES (2001)
Requirement of the JIP1 scaffold protein for stress-induced JNK activation
AJ Whitmarsh et al.
GENES & DEVELOPMENT (2001)
Blocking oncogenic Ras signaling for cancer therapy
AA Adjei
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation ill the mouse mammary gland
JA Schroeder et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3β and β-catenin
YQ Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Signal transduction by the JNK group of MAP kinases
RJ Davis
CELL (2000)
Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation
A Behrens et al.
ONCOGENE (2000)
Share Paper
